Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Development of lung and muscle protein factories to deliver therapeutic monoclonal antibodies

Recombinant therapeutic proteins, of which monoclonal antibodies (mAbs) represent the largest market, are used to treat diseases including cancer, blood and immune disorders. The cost and complexity of large-scale production and purification of mAbs translates to high cost of therapy. We hypothesise...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Antepowicz, A, Tan, A, Pringle, A, Hyde, S, Gill, D
Μορφή: Conference item
Έκδοση: Mary Ann Liebert Inc 2016

Παρόμοια τεκμήρια

Παρόμοια τεκμήρια